These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4070008)

  • 1. In vivo and in vitro inhibition of B16 melanoma growth by vitamin B6.
    DiSorbo DM; Wagner R; Nathanson L
    Nutr Cancer; 1985; 7(1-2):43-52. PubMed ID: 4070008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose pyridoxal supplemented culture medium inhibits the growth of a human malignant melanoma cell line.
    DiSorbo DM; Nathanson L
    Nutr Cancer; 1983; 5(1):10-5. PubMed ID: 6634429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pyridoxine and pyridoxal on the in vitro growth of human malignant melanoma.
    Shultz TD; Santamaria AG; Gridley DS; Stickney DR; Slater JM
    Anticancer Res; 1988; 8(6):1313-8. PubMed ID: 3218963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin B6 suppresses growth and expression of albumin gene in a human hepatoma cell line HepG2.
    Molina A; Oka T; Muńoz SM; Chikamori-Aoyama M; Kuwahata M; Natori Y
    Nutr Cancer; 1997; 28(2):206-11. PubMed ID: 9290129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
    Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A
    Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of inhibition of polyamine biosynthesis by DL-alpha-difluoromethylornithine on the growth and melanogenesis of B16 melanoma in vitro and in vivo.
    Sunkara PS; Chang CC; Prakash NJ; Lachmann PJ
    Cancer Res; 1985 Sep; 45(9):4067-70. PubMed ID: 3928149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of growth of B16 murine malignant melanoma by exogenous interferon.
    Bart RS; Porzio NR; Kopf AW; Vilcek JT; Cheng EH; Farcet Y
    Cancer Res; 1980 Mar; 40(3):614-9. PubMed ID: 6162552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with B16 melanoma cells expressing a secreted form of interleukin-1beta induces tumor growth inhibition and an enhanced immunity against the wild-type B16 tumor.
    Björkdahl O; Dohlsten M; Sjögren HO
    Cancer Gene Ther; 2000 Oct; 7(10):1365-74. PubMed ID: 11059695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of pyridoxal treatment in controlling the growth of melanomas in cell culture and an animal pilot study.
    Maksymowych AB; Robertson NM; Litwack G
    Anticancer Res; 1993; 13(6A):1925-37. PubMed ID: 8297098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of zinc on mouse melanoma growth in vitro and in vivo.
    Borovanský J; Riley PA; Vránková E; Necas E
    Neoplasma; 1985; 32(4):401-6. PubMed ID: 4047252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro growth inhibition of human malignant melanoma cells by glucocorticoids.
    DiSorbo DM; McNulty B; Nathanson L
    Cancer Res; 1983 Jun; 43(6):2664-7. PubMed ID: 6850583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of honey bee venom on proliferation of K1735M2 mouse melanoma cells in-vitro and growth of murine B16 melanomas in-vivo.
    Liu X; Chen D; Xie L; Zhang R
    J Pharm Pharmacol; 2002 Aug; 54(8):1083-9. PubMed ID: 12195822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene transfer of a soluble receptor of VEGF inhibits the growth of experimental eyelid malignant melanoma.
    Shiose S; Sakamoto T; Yoshikawa H; Hata Y; Kawano Y; Ishibashi T; Inomata H; Takayama K; Ueno H
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2395-403. PubMed ID: 10937546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
    Chan P
    Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 receptor antagonist inhibits subcutaneous B16 melanoma growth in vivo.
    McKenzie RC; Oran A; Dinarello CA; Sauder DN
    Anticancer Res; 1996; 16(1):437-41. PubMed ID: 8615650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of pyridoxal 5'-phosphate on endothelial cell proliferation, replicative DNA polymerase and DNA topoisomerase.
    Matsubara K; Matsumoto H; Mizushina Y; Lee JS; Kato N
    Int J Mol Med; 2003 Jul; 12(1):51-5. PubMed ID: 12792808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antitumour effect of total saponins of Rubus parvifolius on malignant melanoma].
    Zheng ZX; Zhang LJ; Huang CX; Huang QL; Wei XD; Wu XY; Zhou WM
    Zhongguo Zhong Yao Za Zhi; 2007 Oct; 32(19):2055-8. PubMed ID: 18161304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro.
    Qin Y; Ertl T; Cai RZ; Halmos G; Schally AV
    Cancer Res; 1994 Feb; 54(4):1035-41. PubMed ID: 8313359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.